Kevin Yee

1.4k citations
12 papers · 1.2k · 1 hit paper · h-index 9

Impact in

  • Hematology top 2%
    • Acute Myeloid Leukemia Research
    • Chronic Myeloid Leukemia Treatments
  • Genetics top 5%
    • Chronic Lymphocytic Leukemia Research
    • Myeloproliferative Neoplasms: Diagnosis and Treatment

Papers in

    • Chronic Myeloid Leukemia Treatments 6
    • Acute Myeloid Leukemia Research 5
    • Chronic Lymphocytic Leukemia Research 2
    • Myeloproliferative Neoplasms: Diagnosis and Treatment 2

Kevin Yee

12 papers receiving 1.2k citations

Kevin Yee's Hit Papers

SU11248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivo 2003 · 703 citations
7030+7+15Years since publication200400600

Peers

Kevin Yee
Comparison fields: 5 of 64
  • Hematology 458
  • Genetics 222
  • Gastroenterology 76
  • Pulmonary and Respiratory Medicine 272
  • Oncology 227
Replace Sharianne G. Louie with:
Sharianne G. Louie United States
Paola Aimone Switzerland
Toshiki Iwai Japan
Mary Jo Lehman United States
Ron Paquette United States
Darrin M. Beaupre United States
Aaron Weitzman United States
T Fujimoto Japan
Paul Conkling United States
Anne-Marie O’Farrell United States
Kevin Yee relative to Sharianne G. Louie United States Sharianne G. Louie's profile →
Citations per field
00.5×1.5×
Sharianne G. Louie · 1×
Citations per year

Countries citing papers authored by Kevin Yee

Since Specialization
Citations

This map shows the geographic impact of Kevin Yee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Yee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Yee more than expected).

Fields of papers citing papers by Kevin Yee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin Yee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Yee. The network helps show where Kevin Yee may publish in the future.

Co-authors

The 25 scholars most cited alongside Kevin Yee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kevin Yee Line = papers co-authored together Kevin Yee links everyone, so they are left out of the graph.

All Works

12 of 12 papers shown
#Work
1
SU11248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivo
Hit paper breakdown →
2003703
2 2002140
3 2004103
4 200459
5 200355
6 200636
7 200932
8 199931
9
Cancers of the gallbladder and biliary ducts.
200228
10 20207
11 20003
12 20221

About Kevin Yee

Kevin Yee is a scholar working on Hematology, Genetics, Pulmonary and Respiratory Medicine, Rheumatology and Pharmacology, having authored 12 papers that have together received 1.2k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (6 papers), Acute Myeloid Leukemia Research (5 papers), Pharmacogenetics and Drug Metabolism (2 papers), Cystic Fibrosis Research Advances (2 papers), Chronic Lymphocytic Leukemia Research (2 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers), Tracheal and airway disorders (2 papers) and Eosinophilic Disorders and Syndromes (2 papers). The work is most often cited by research in Hematology (458 citations), Genetics (222 citations), Gastroenterology (76 citations), Pulmonary and Respiratory Medicine (272 citations) and Oncology (227 citations). Kevin Yee has collaborated with scholars based in United States, Germany and Puerto Rico. Frequent co-authors include Michael C. Heinrich, Julie M. Cherrington, Ajia Town, Beverly D. Smolich, Leslie B. Lee, William C. Manning, Sharianne G. Louie, Tinya J. Abrams, Lesley Murray and Laura McGreevey. Their work appears in journals such as Blood, Clinical and Translational Science, Human Genetics, Leukemia and Bioorganic & Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact